Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.55 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | KCNN4 | O15554 | 7/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | KIF11 | P52732 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.42 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.42 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.41 |
| ▸ | DRD2 | P14416 | 1/20 | 0.40 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.40 |
| ▸ | DRD3 | P35462 | 1/20 | 0.40 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL262672 | 0.83 | CYP2C19 (0.47) | MAPTKMT2AHTTKCNN4CYP2C19 | |
| SCHEMBL13946506 | 0.79 | MAPT (0.55) | MAPTKMT2AHTTKCNN4CYP2C19 | |
| SCHEMBL3837958 | 0.79 | MAPT (0.55) | MAPTKMT2AHTTKCNN4CYP2C19 | |
| SCHEMBL4030430 | 0.79 | MAPT (0.55) | MAPTKMT2AHTTKCNN4CYP2D6 | |
| SCHEMBL13946510 | 0.79 | MAPT (0.55) | MAPTKMT2AHTTKCNN4CYP2C19 | |
| SCHEMBL431187 | 0.79 | HTT (0.59) | MAPTKMT2AHTTKCNN4CYP2C19 | |
| Phenylethylmalonamide SCHEMBL341785 | 0.79 | MAPT (0.55) | MAPTKMT2AHTTKCNN4CYP2C19 | |
| Hydrochloric Acid SCHEMBL5252883 | 0.78 | MAPT (0.53) | MAPTKMT2AHTTKCNN4CYP2D6 | |
| Phenylethylmalonamide SCHEMBL29755357 | 0.78 | MAPT (0.53) | MAPTKMT2AHTTKCNN4CYP2C19 | |
| SCHEMBL2030597 | 0.78 | MAPT (0.59) | MAPTKMT2AHTTKCNN4CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103242230-B | Quinolinone derivative and preparation method thereof | SHAANXI BUCHANG HI TECH PHARMACEUTICAL CO LTD | 2015-02-18 | — | — | CN | disclosed |
| US-20100216791-A1 | PYRIDINYLQUINAZOLINAMINE DERIVATIVES AND THEIR USE AS B-RAF INHIBITORS | ASTRAZENECA (SE) | 2010-08-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100216791-A1 | PYRIDINYLQUINAZOLINAMINE DERIVATIVES AND THEIR USE AS B-RAF INHIBITORS | BRAF, RAF1, ARAF | MAPT 4079/4885KMT2A 2325/4885HTT 4823/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.